Literature DB >> 22126844

Higher complication risk of totally implantable venous access port systems in patients with advanced cancer - a single institution retrospective analysis.

Yi-Fang Chang1, An-Chi Lo, Chung-Hsin Tsai, Pei-Yi Lee, Shen Sun, Te-Hsin Chang, Chien-Chuan Chen, Yuan-Shin Chang, Jen-Ruei Chen.   

Abstract

BACKGROUND: Totally implantable port systems are generally recommended for prolonged central venous access in diverse settings, but their risk of complications remains unclear for patients with advanced cancer. AIM: The aim of this study was to assess the risk of port system failure in patients with advanced cancer.
DESIGN: We conducted a retrospective cohort study in a comprehensive cancer centre. SETTING/PARTICIPANTS: A detailed chart review was conducted among 566 patients with 573 ports inserted during January-June, 2009 (average 345.3 catheter-days). Cox regression analysis was applied to evaluate factors during insertion and early maintenance that could lead to premature removal of the port systems due to infection or occlusion.
RESULTS: Port system-related infection was significantly associated with receiving palliative care immediately after implantation (hazard ratio, HR = 7.3, 95% confidence interval, 95% CI = 1.2-46.0), after adjusting for probable confounders. Primary cancer site also impacted the occurrence of device-related infection. Receiving oncologic/palliative care (HR = 3.0, P = 0.064), advanced cancer stage (HR = 6.5, P = 0.077) and body surface area above 1.71 m(2) (HR = 3.4, P = 0.029) increased the risk of port system occlusion.
CONCLUSIONS: Our study indicates that totally implantable port systems yield a higher risk of complications in terminally ill patients. Further investigation should be carefully conducted to compare outcomes of various central venous access devices in patients with advanced cancer and to develop preventive strategies against catheter failure.

Entities:  

Mesh:

Year:  2011        PMID: 22126844     DOI: 10.1177/0269216311428777

Source DB:  PubMed          Journal:  Palliat Med        ISSN: 0269-2163            Impact factor:   4.762


  10 in total

1.  Clearing obstructed totally implantable central venous access ports: an efficient protocol using a second needle.

Authors:  Sonia Muguet; Sébastien Couraud; Emilie Perrot; Isabelle Claer; Pierre Jean Souquet
Journal:  Support Care Cancer       Date:  2012-03-02       Impact factor: 3.603

2.  A comparison of outcomes and complications of totally implantable access port through the internal jugular vein versus the subclavian vein.

Authors:  Yoshinobu Nagasawa; Tomoharu Shimizu; Hiromichi Sonoda; Eiji Mekata; Masato Wakabayashi; Hiroyuki Ohta; Satoshi Murata; Tsuyoshi Mori; Shigeyuki Naka; Tohru Tani
Journal:  Int Surg       Date:  2014 Mar-Apr

3.  Score of liver ultrasonography predicts treatment-related severe neutropenia and neutropenic fever in induction chemotherapy with docetaxel for locally advanced head and neck cancer patients with normal serum transamines.

Authors:  Ting-Yao Wang; Wei-Ming Chen; Lan-Yan Yang; Chao-Yu Chen; Wen-Chi Chou; Yi-Yang Chen; Chih-Cheng Chen; Kuan-Der Lee; Chang-Hsien Lu
Journal:  Support Care Cancer       Date:  2016-06-21       Impact factor: 3.603

4.  Role of Lock Therapy for Long-Term Catheter-Related Infections by Multidrug-Resistant Bacteria.

Authors:  Maristela P Freire; Ligia C Pierrotti; Antonio E Zerati; Luciana Benites; Joaquim Mauricio da Motta-Leal Filho; Karim Y Ibrahim; Pedro H Araujo; Edson Abdala
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

5.  Increased rates of local complication of central venous catheters in the targeted anticancer therapy era: a 2-year retrospective analysis.

Authors:  R Berardi; S Rinaldi; D Santini; B Vincenzi; R Giampieri; E Maccaroni; F Marcucci; M Francoletti; A Onofri; A Lucarelli; C Pierantoni; G Tonini; S Cascinu
Journal:  Support Care Cancer       Date:  2014-10-19       Impact factor: 3.603

6.  Activity of ethanol and daptomycin lock on biofilm generated by an in vitro dynamic model using real subcutaneous injection ports.

Authors:  C Aumeran; P Guyot; M Boisnoir; C Robin-Hennequin; M Vidal; C Forestier; O Traore; O Lesens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-10-19       Impact factor: 3.267

7.  Totally implantable venous access port systems and associated complications: A single-institution retrospective analysis of 2,996 breast cancer patients.

Authors:  L I Ma; Yueping Liu; Jianxin Wang; Yuan Chang; Long Yu; Cuizhi Geng
Journal:  Mol Clin Oncol       Date:  2016-01-07

8.  A Study of Use of "PORT" Catheter in Patients with Cancer: A Single-Center Experience.

Authors:  Irappa Madabhavi; Apurva Patel; Malay Sarkar; Asha Anand; Harsha Panchal; Sonia Parikh
Journal:  Clin Med Insights Oncol       Date:  2017-02-23

9.  Impact of chest subcutaneous fat on the occurrence of central venous port-related infectious complications in cancer patients.

Authors:  Jumpei Shibata; Hidetaka Kawamura; Kazuhiro Hiramatsu; Michitaka Honda; Yoshihisa Shibata; Taro Aoba; Masahiro Fujii; Atsuki Arimoto; Akira Ito; Kenta Ishii; Kojiro Omiya; Mariko Asai; Takuya Arakawa; Hirotake Gonda; Shuhei Asai; Takuya Hasegawa; Kento Kawashima; Takehito Kato
Journal:  Support Care Cancer       Date:  2021-03-10       Impact factor: 3.603

10.  Outcomes following port-a-catheter placement in the Medicare population.

Authors:  Syed I Khalid; Samantha Maasarani; Rachyl M Shanker; Aaron Lee Wiegmann; Rita Wu; Nicholas J Skertich; Samantha L Terranella; Laura DeCesare; Edie Y Chan
Journal:  Surg Open Sci       Date:  2020-11-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.